Your browser doesn't support javascript.
loading
Crystallography, Molecular Modeling, and COX-2 Inhibition Studies on Indolizine Derivatives.
Venugopala, Katharigatta N; Chandrashekharappa, Sandeep; Tratrat, Christophe; Deb, Pran Kishore; Nagdeve, Rahul D; Nayak, Susanta K; Morsy, Mohamed A; Borah, Pobitra; Mahomoodally, Fawzi M; Mailavaram, Raghu Prasad; Attimarad, Mahesh; Aldhubiab, Bandar E; Sreeharsha, Nagaraja; Nair, Anroop B; Alwassil, Osama I; Haroun, Michelyne; Mohanlall, Viresh; Shinu, Pottathil; Venugopala, Rashmi; Kandeel, Mahmoud; Nandeshwarappa, Belakatte P; Ibrahim, Yasmine F.
Afiliação
  • Venugopala KN; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
  • Chandrashekharappa S; Department of Biotechnology and Food Technology, Durban University of Technology, Durban 4001, South Africa.
  • Tratrat C; Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER-R) Raebareli, Lucknow UP 226002, India.
  • Deb PK; Institute for Stem Cell Science and Regenerative Medicine, NCBS, TIFR, GKVK, Bellary Road, Bangalore 560065, India.
  • Nagdeve RD; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
  • Nayak SK; Faculty of Pharmacy, Philadelphia University, Amman 19392, Jordan.
  • Morsy MA; Department of Chemistry, Visvesvaraya National Institute of Technology, Nagpur 440010, Maharashtra, India.
  • Borah P; Department of Chemistry, Visvesvaraya National Institute of Technology, Nagpur 440010, Maharashtra, India.
  • Mahomoodally FM; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
  • Mailavaram RP; Department of Pharmacology, Faculty of Medicine, Minia University, El-Minia 61511, Egypt.
  • Attimarad M; Pratiksha Institute of Pharmaceutical Sciences, Chandrapur Road, Panikhaiti, Guwahati 781026, Assam, India.
  • Aldhubiab BE; Department of Health Sciences, Faculty of Medicine and Health Sciences, University of Mauritius, Réduit 80835, Mauritius.
  • Sreeharsha N; Department of Pharmaceutical Chemistry, Shri Vishnu College of Pharmacy, Vishnupur, Bhimavaram 534202, India.
  • Nair AB; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
  • Alwassil OI; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
  • Haroun M; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
  • Mohanlall V; Department of Pharmaceutics, Vidya Siri College of Pharmacy, Off Sarjapura Road, Bangalore 560035, India.
  • Shinu P; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
  • Venugopala R; Department of Pharmaceutical Sciences, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh 11481, Saudi Arabia.
  • Kandeel M; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
  • Nandeshwarappa BP; Department of Biotechnology and Food Technology, Durban University of Technology, Durban 4001, South Africa.
  • Ibrahim YF; Department of Biomedical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
Molecules ; 26(12)2021 Jun 10.
Article em En | MEDLINE | ID: mdl-34200764
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Ciclo-Oxigenase 2 / Indolizinas Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Ciclo-Oxigenase 2 / Indolizinas Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article